Our Board of Directors

Professor Coghill is committed to the development and implementation of evidence-based pathways for ADHD and has been involved in the development of several National and International Clinical guidelines for ADHD. David’s research interests include neuroscience, neuropsychology, Neuropsychopharmacology, health services research, implementation science, clinical trials, pharmacovigilance and quality of life. He is the chair of EUNETHYDIS International conferences and is a longstanding member of the executive committee of the European Network for Hyperkinetic Disorders (EUNETHYDIS).

Dr Sarahn Lovett is a General Paediatrician for both public and private systems.  Dr Lovett is the Clinical Lead for ADHD Shared Care at Hunter New England and has led the development of a dedicated ADHD clinic that opened in HNEHealth in late 2023.  Dr Lovett is currently working with NSW Health to develop an online ADHD education module to help all clinicians participate in ADHD shared models care.  She is a passionate advocate for equitable and evidenced-based support for neurodiverse children and understands the importance of developing pathways to provide these supports efficiently and effectively across an individual’s lifespan is her goal.

Professor Bellgrove has studied the neurobiology of ADHD for over 15 years and is internationally known for his work on the genetics, neuropsychology and pharmacology of ADHD. His research has been recognized with awards from NARSAD, the Academy of Social Sciences in Australia and Biological Psychiatry Australia. Mark is a strong advocate for evidence-based diagnosis, treatment and management of ADHD and has a strong vision for the development of unified national diagnosis, prescribing and treatment practices and AADPA’s role in influencing policy to ensure a “better deal” for the many individuals affected by ADHD within Australia.

Katarzyna (Kate) Tognarini, B.Sc (Hons), B.Pharm is a practising community pharmacist in Melbourne, with over 25 years of experience working in community, education, industry and hospital. She is an MPS-endorsed vaccinator (Vic) and has certification in General Practice Pharmacy and Mental Health First Aid (Adult and Youth). Kate is a relative newcomer to ADHD given her family history and experience. She has a goal of improving ADHD education and training among Pharmacists and would like to enhance interprofessional collaboration in this area, with a view to achieving better overall outcomes. Kate has worked with current AADPA Board members and experienced specialists to coordinate the writing of the upcoming ADHD Prescriber Manual.

Rebecca Alexander is a Clinical Psychologist specializing in ADHD diagnosis and treatment across the lifespan. She holds a Bachelor of Psychology (Honours) and Masters in Professional and Clinical Psychology (Advanced). With seven years’ experience in evidence-based practices, Rebecca collaborates with parents, schools, and professionals while facilitating workshops offering practical ADHD management tools. As a member of the AADPA Education Committee, she combines her clinical expertise with background in corporate governance to advance ADHD awareness and treatment accessibility.

Dr. Chris Soo is a GP and physiotherapist with lived experience of AuDHD, who practices full-time ADHD management. Since 2010, he has advocated for the ADHD community, co-founding the QLD ADHD GP Alliance and National Council of ADHD GPs. As a member of AADPA’s Education & Training Committee, Dr. Soo works to destigmatize ADHD within the medical community while enhancing collaboration between specialties and improving access to quality care across Australia and New Zealand.

Dr. Kyle Hoath is a private psychiatrist specializing in adult ADHD diagnosis and management, with expertise in comorbidities and ADHD in elite athletes. Drawing from seven years of clinical and lived ADHD experience, he founded Oqea to improve access to mental health care. As a non-executive director for AMA(WA) and Member of the Australian Institute of Company Directors, Dr. Hoath contributes to ADHD policy development and advocates for enhanced government support of ADHD services.

Dr. Sarah Watson is a senior Child & Adolescent Clinical Psychologist and the Founder of Totally Psyched, a multidisciplinary practice with clinics in Auckland’s North Shore and Warkworth. With over twenty years’ experience across mental health, education, and leadership, Sarah has worked in New Zealand’s Child & Adolescent Mental Health Services (CAMHS) as both a clinician and Clinical Lead, and in the UK’s South London & Maudsley services supporting children in residential care. She is a frequent media contributor, guest lecturer, and trainer for health, education, and social service professionals nationwide. Sarah is also the Clinical Advisor for ADHD NZ and remains committed to clinical practice, focusing on neurodevelopmental conditions such as ADHD, ASD, and OCD.

Dr Will Errington is a GP with a special interest in ADHD, eating disorders, men’s health and professional wellbeing. He holds a Diploma in Child Health and brings a broad, multidisciplinary perspective to clinical care across the lifespan. Will has extensive experience in medical education, having worked as a registrar supervisor, examiner and Medical Educator with the Royal Australian College of General Practitioners. He has also held academic appointments at the University of New South Wales and Imperial College London. Prior to medicine, he worked in investment banking and private equity, including with Macquarie Bank, bringing a unique commercial and systems perspective to healthcare.

Nikki Searby is a seasoned commercial lawyer with a wide breadth of exposure to different areas of law, international recruitment, cross-cultural human resources, customer and client relations, billing and contract management and event coordination. Nikki has a passion for advocacy and inclusivity, particularly within neurodiverse workplaces. In addition to her role as Company Secretary, Nikki is also Chair of our 8th Annual Conference.